Pictet Asset Management Holding SA Purchases Shares of 12,839 Cellebrite DI Ltd. (NASDAQ:CLBT)

Pictet Asset Management Holding SA acquired a new position in shares of Cellebrite DI Ltd. (NASDAQ:CLBT) during the 4th quarter, Holdings Channel.com reports. The fund acquired 12,839 shares of the company’s stock, valued at approximately $283,000.

Other institutional investors also recently modified their holdings of the company. True Wind Capital Management L.P. lifted its stake in Cellebrite DI by 18.2% during the fourth quarter. True Wind Capital Management L.P. now owns 13,861,007 shares of the company’s stock worth $305,358,000 after purchasing an additional 2,130,386 shares during the period. Principal Financial Group Inc. acquired a new position in shares of Cellebrite DI in the 3rd quarter worth approximately $23,402,000. Lord Abbett & CO. LLC bought a new position in shares of Cellebrite DI during the 3rd quarter worth approximately $11,523,000. Raymond James Financial Inc. bought a new position in shares of Cellebrite DI during the 4th quarter worth approximately $9,995,000. Finally, Bank Julius Baer & Co. Ltd Zurich acquired a new stake in Cellebrite DI in the 4th quarter valued at $8,126,000. Institutional investors and hedge funds own 45.88% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have issued reports on the company. Needham & Company LLC reissued a “buy” rating and set a $28.00 price objective on shares of Cellebrite DI in a report on Wednesday, April 2nd. JPMorgan Chase & Co. boosted their price target on shares of Cellebrite DI from $24.00 to $28.00 and gave the company an “overweight” rating in a research report on Tuesday, February 11th. Finally, Lake Street Capital upped their price objective on shares of Cellebrite DI from $17.00 to $26.00 and gave the stock a “buy” rating in a research note on Friday, February 14th. Seven equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus target price of $23.43.

Cellebrite DI Trading Down 0.8 %

Shares of CLBT opened at $18.82 on Friday. The stock has a market cap of $4.51 billion, a P/E ratio of -13.54, a price-to-earnings-growth ratio of 4.27 and a beta of 1.44. Cellebrite DI Ltd. has a 1 year low of $10.25 and a 1 year high of $26.30. The stock’s 50-day moving average price is $19.74 and its two-hundred day moving average price is $19.98.

Cellebrite DI (NASDAQ:CLBT) last released its quarterly earnings data on Thursday, February 13th. The company reported $0.07 earnings per share for the quarter, missing the consensus estimate of $0.10 by ($0.03). Cellebrite DI had a positive return on equity of 58.70% and a negative net margin of 70.54%. As a group, equities analysts forecast that Cellebrite DI Ltd. will post 0.3 EPS for the current year.

Cellebrite DI Company Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.